thrombosis.

Educational Objective:

CREST syndrome (limited scleroderma) manifests with calcinosis, Raynaud's phenomenon,
esophageal dysmotility, sclerodactyly and telangiectasias. Anti-centromere antibodies are
found in about 40% of patients with CREST syndrome. Anti-DNA topoisomerase | (Scl-70)
antibodies are highly specific for systemic sclerosis.
